iSERA LIFESCIENCES share news and announcements
BSE: 534920IT - SoftwareSmall Cap
Share price at the BSE close on 23 Oct 2026. Previous close ₹143.90.
- Under BSE's graded surveillance, stage 0, on the list for 22 Oct 2026. The exchange puts a share here when its price has moved unusually, and trading in it carries extra conditions.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- Differs from the exchange's3,450th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit.
- Differs from the exchange's
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet.
- Differs from the exchange's
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- –
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the latest balance sheet's; the one a year before is not on record.
- −0.7%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- −0.7%
- Volume, BSEVolume. Shares traded on the last trading day.
- 1,471
iSERA LIFESCIENCES share news and announcements
600 announcements, routine notices left out, newest first. Page 4 of 12.
Aug 2024
May 2024
21 May · Board meeting
Meeting on 29 May 2024: audited results
Apr 2024
22 Apr · Regulation 40 (10) - PCS Certificate For Transfer/ Transmission/ Transposition
19 Apr · Compliance Certificate Pursuant To Regulation 7(3) Of SEBI (LODR) 2015.
6 Apr · Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2
Mar 2024
7 Mar · Board meeting
Meeting on 7 Mar 2024: preferential issue of shares, reduction of capital and scheme of arrangement
Feb 2024
Jan 2024
25 Jan · Board meeting
Meeting on 8 Feb 2024: quarterly results
Nov 2023
2 Nov · Board meeting
Meeting on 10 Nov 2023: quarterly results
Oct 2023
Sep 2023
8 Sep · Corporate action
Aug 2023
29 Aug · Board meeting
Meeting on 5 Sep 2023: annual general meeting11 Aug · Results
11 Aug · Results
4 Aug · Board meeting
Meeting on 11 Aug 2023: quarterly results
May 2023
23 May · Board meeting
Meeting on 29 May 2023: audited results
Apr 2023
30 Apr · Compliance Certificate Reg.40(9) Year Ended 31.03.2023
29 Apr · Compliance Certificate Under Regulation 7(3) Of Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations,2015 For The Year Ended 31.03.2023
Feb 2023
6 Feb · Board meeting
Meeting on 13 Feb 2023: quarterly results
Nov 2022
4 Nov · Board meeting
Meeting on 14 Nov 2022: quarterly results
Oct 2022
20 Oct · Statement Of Investor Complaints For The Quarter Ended September 2022
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 0
Sep 2022
30 Sep · Meeting